CIDP Patient Perspectives on IG Treatment

Posted on
image of people talking to a doctor

CIDP Patient Perspectives on IG Treatment

A research team is looking for participants for a market research study on treatments for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). If you currently receive immunoglobulin (or Ig) therapy for CIDP, you might be a good fit for this study. Help others with CIDP by participating in this important research.

Details:

  • 60-minute phone interview to be scheduled at a convenient time
  • Computer or laptop needed – video conferencing software will be used to show materials
  • If you qualify and complete the interview, you will receive $125 in compensation
  • The research is confidential – your personal information will not be shared
  • Complete a short screener to see if you qualify using this link: Click Here

Contact Vincent.Tagliareni@SchlesingerGroup.com with any questions